Abatacept biosimilar (BioXpress)

阿巴西普生物类似药（BioXpress）

Report date: 2025/03/07 17:33:50

Base Information

Drug NameAbatacept biosimilar (BioXpress)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar

Mechanisms of ActionCluster of differentiation 80 modulatorsCluster of differentiation 86 modulators

TargetsCluster of differentiation 80Cluster of differentiation 86

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A